chemotherapy

New ‘Chemoimmunotherapy’ Proves Potent Against Prostate Cancers

In spite of aggressive chemotherapy treatments, advanced prostate cancers have proven to be quite difficult to treat. As a heterogeneous mass of different cancerous mutations, prostate tumors often evade cellular death, and have even been known to accumulate cells capable of suppressing a body’s immunological defenses. But in a new study published this week in the journal Nature, researchers have found that chemotherapy, when paired with immunotherapy, is a potent duo that has already proven successful in achieving prostate cancer remission in mouse models—now they think that the strategy may be ready to treat humans.

New Issue of ‘Science’ Tackles Individualized Immunotherapies and the Future of Cancer Research

When it comes to tackling important issues within the science community that address realistic needs of the public, few publications are quite as thoughtful as the journal Science when it comes to curating the best of the best research, in any given field. Though the journal often covers a wide breadth of topics, this week they’re headed in a new direction, talking about game-changing cancer immunotherapy and the future possibility of individualized treatments that will take every patient’s genetic makeup and mutations into consideration. And it has become a conversation led by many hopeful researchers at the helm, backed by promising data.

State Enforced Chemo Clears Cancer—But The Teen Is Still Angry

A 17-year-old girl who initially refused treatment for a highly curable cancer was forced by the state to undergo treatment after she and her mother refused. Now, thanks to the life-saving chemotherapy she received, the teenager is now in remission and has requested to return home. And while she may be eager to go home, she's still angry about the way her case publically transpired.

Recommended Stories

Real Time Analytics